Matthias Derwent: New Migraine Therapies
New Migraine Therapies
Buch
- Antibodies, CGRP Inhibitors, Neuromodulation Techniques, Gepanten, Ditane, etc.
- Bremen University Press, 09/2024
- Einband: Kartoniert / Broschiert, Paperback
- Sprache: Englisch
- ISBN-13: 9783689048990
- Bestellnummer: 11974333
- Umfang: 128 Seiten
- Gewicht: 191 g
- Maße: 216 x 140 mm
- Stärke: 10 mm
- Erscheinungstermin: 23.9.2024
Achtung: Artikel ist nicht in deutscher Sprache!
Klappentext
Migraine is one of the most complex neurological disorders and affects millions of people worldwide. Despite numerous therapeutic approaches, it remains a difficult challenge to treat for many sufferers. However, the latest research findings open up promising prospects: from innovative medications to non-invasive technologies and lifestyle interventions - migraine therapy is changing. This book provides a comprehensive overview of the latest developments in migraine research and presents promising therapies. These include CGRP antibodies, which specifically intervene in the mechanism of migraine development and have proven to be a ground-breaking prevention option. Neuromodulation techniques such as transcutaneous vagus nerve stimulation and transcranial magnetic stimulation have also shown impressive results in clinical trials and offer a non-drug alternative for treatment. The book also sheds light on the role of nutrition, in particular the ketogenic diet, and its influence on migraine susceptibility. Herbal remedies such as butterbur and feverfew are also discussed as natural alternatives to drug therapy. Another chapter is dedicated to the importance of the gut-brain axis and the possibility of influencing migraines by taking probiotics. With an in-depth look at current research findings and their possible applications, this book offers a sound guide for patients, doctors and scientists. Discover how these new approaches can help prevent and alleviate migraine attacks and improve the lives of sufferers in the long term.Anmerkungen:
Bitte beachten Sie, dass auch wir der Preisbindung unterliegen und kurzfristige Preiserhöhungen oder -senkungen an Sie weitergeben müssen.
Matthias Derwent
New Migraine Therapies
EUR 30,00*